ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515,624 | -41.8% | 112,092 | -18.3% | 0.00% | – |
| Q2 2023 | $886,609 | +139.4% | 137,246 | +179.4% | 0.00% | – |
| Q1 2023 | $370,380 | +84.0% | 49,122 | +147.2% | 0.00% | – |
| Q4 2022 | $201,293 | -18.8% | 19,871 | -20.8% | 0.00% | – |
| Q3 2022 | $248,000 | -43.9% | 25,101 | -39.5% | 0.00% | – |
| Q2 2022 | $442,000 | -95.8% | 41,502 | -96.2% | 0.00% | -100.0% |
| Q1 2022 | $10,510,000 | -44.8% | 1,078,000 | -19.1% | 0.00% | -50.0% |
| Q4 2021 | $19,048,000 | -33.5% | 1,331,946 | -6.8% | 0.01% | -40.0% |
| Q3 2021 | $28,640,000 | +96.1% | 1,429,157 | +115.3% | 0.01% | +66.7% |
| Q2 2021 | $14,605,000 | +800.4% | 663,921 | +1289.9% | 0.01% | +500.0% |
| Q1 2021 | $1,622,000 | +169.9% | 47,767 | +220.1% | 0.00% | – |
| Q4 2020 | $601,000 | – | 14,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |